Transce3nd, LLC Harvard Bioscience Inc Transaction History
Transce3nd, LLC
- $295 Billion
- Q4 2024
A detailed history of Transce3nd, LLC transactions in Harvard Bioscience Inc stock. As of the latest transaction made, Transce3nd, LLC holds 938 shares of HBIO stock, worth $1,266. This represents 0.0% of its overall portfolio holdings.
Number of Shares
938Holding current value
$1,266% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding HBIO
# of Institutions
98Shares Held
31.2MCall Options Held
700Put Options Held
2.1K-
Black Rock Inc. New York, NY2.84MShares$3.84 Million0.0% of portfolio
-
Punch & Associates Investment Management, Inc. Edina, MN2.76MShares$3.72 Million0.35% of portfolio
-
Harvey Partners, LLC Tarrytown, NY2.68MShares$3.62 Million0.66% of portfolio
-
Amh Equity LTD2.5MShares$3.38 Million5.77% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.16MShares$2.91 Million0.0% of portfolio
About HARVARD BIOSCIENCE INC
- Ticker HBIO
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 41,636,500
- Market Cap $56.2M
- Description
- Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products, and services that enables fundamental research, discovery, and pre-clinical testing for drug development in the United States and internationally. The company offers cellular and molecular technology instruments, such as syringe and peristaltic pump products, as w...